Fermenta Biotech Q1 results, quarter to Jun 2026

NSE: FERMENTABSE: 506414Pharmaceuticals & BiotechnologySmall Cap

Fermenta Biotech Limited · Face value ₹5 · Listed Oct 1977 on BSE, Apr 2026 on NSE

₹417.55₹21.55 (4.91%)BSE ₹417.55

Share price at the NSE close on 30 Oct 2026. Previous close ₹439.10.

30 Oct: open ₹439.00, high ₹440.75, low ₹411.30

52-week range of BSE trades to 30 Oct 2026

₹256.40Low, 5 Dec 2025₹582.95High, 6 Oct 2026

Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar

Market cap: ₹1,229 Cr1,508th largest listed
P/E: Earlier quarters restated in the year
P/B: 3.03
Dividend yield: 0.90%
ROCE: 13.5%
Debt to equity: 0.27
Volume, NSE: 42,29254.6% delivered

Fermenta Biotech filed its Q1 results for the quarter to Jun 2026 on 11 Aug 2026 at 10:17 pm, consolidated: the company and its subsidiaries together.

Q1 results, quarter to Jun 2026

₹ crore.Fermenta Biotech annual results and balance sheet

Revenue: ₹122 Cr−10.6% on a year ago · +0.2% on the quarter before
Operating profit: ₹18 Cr−36.1% on a year ago · −9.7% on the quarter before
Net profit: ₹9.53 Cr−55.9% on a year ago · −48.8% on the quarter before
Earnings per share: ₹3.40−54.6% on a year ago · −48.9% on the quarter before
Operating margin: 14.8%
Net margin: 7.8%

From revenue to net profit, ₹ crore

Revenue122
Materials and goods−42
Employee costs−23
Other expenses−39
Operating profit18
Depreciation−5.2
Other income+4.4
Finance costs−2.5
Profit before tax15
Tax−5.2
Net profit9.5

Fermenta Biotech results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.Results filings and date

Revenue and net profit by quarter, ₹ crore

Revenue
Net profit
Loss

Peak revenue ₹156 Cr, quarter to Dec 2024; lowest ₹57 Cr, quarter to Sep 2023A loss in 3 of the 12 quarters shown

Operating and net margin by quarter, per cent

Operating margin
Net margin

₹ crore	Sep 2021	Dec 2021Q3	Mar 2022	Jun 2022Q1	Sep 2022	Dec 2022Q3	Mar 2023	Jun 2023Q1	Sep 2023	Dec 2023Q3	Mar 2024	Jun 2024Q1	Sep 2024	Dec 2024Q3	Mar 2025Q4	Jun 2025Q1	Sep 2025Q2	Dec 2025Q3	Mar 2026Q4	Jun 2026Q1Filed 11 Aug
Revenue from operations	100	93	96	92	98	55	105	82	57	99	97	78	95	156	140	136	130	137	122	122
	84	91	78	87	95	65	86	72	71	74	91	77	76	103	103	108	104	112	102	104
Materials and goods bought	37	42	36	40	47	22	44	30	31	32	38	29	26	42	50	47	47	52	42	42
Employee costs	17	17	12	16	15	15	13	15	14	15	15	16	15	17	17	20	20	21	21	23
Other expenses	30	32	30	31	33	28	29	27	25	28	39	32	35	44	36	41	37	40	39	39
Operating profit before depreciation	16	2	18	5	3	−10	20	11	−14	25	6	1	19	53	37	28	27	25	20	18
Operating margin	15.7%	2.4%	18.5%	5.4%	3.4%	−17.9%	18.6%	13.3%	−24.5%	25.4%	6.1%	1.0%	19.8%	34.0%	26.4%	20.7%	20.5%	18.2%	16.5%	14.8%
Depreciation and amortisation	6	7	6	7	9	6	6	6	6	6	6	6	6	6	6	6	5	5	5	5
Other income	2	1	3	4	3	0	1	2	2	3	5	3	3	2	4	9	5	3	5	4
Finance costs	4	4	4	4	5	5	6	5	4	5	3	3	4	4	3	3	3	3	3	3
Profit before one-off items and tax	7	−7	10	−2	−8	−21	8	2	−22	16	1	−6	12	45	32	28	24	20	17	15
One-off items	0	0	0	0	0	−19	−9	0	−7	0	0	0	0	0	0	0	0	−2	9	0
Profit before tax	7	−7	10	−2	−8	−41	−1	2	−29	16	1	−6	12	45	32	28	24	17	26	15
	3	1	2	0	1	−3	4	0	0	6	8	0	1	7	−1	6	6	5	8	5
Current tax	2	1	2	0	0	−3	2	0	0	6	2	0	1	7	5	4	4	4	4	4
Deferred tax	1	0	0	0	0	0	2	0	0	0	6	0	0	0	−6	2	2	2	4	1
Tax rate	41.9%	–	20.6%	–	–	–	–	0.0%	–	37.8%	886.0%	–	5.9%	16.4%	−4.2%	23.1%	25.1%	31.2%	29.0%	35.1%
	4	−8	8	−3	−8	−38	−5	2	−29	10	−7	−6	11	38	33	22	18	12	19	10
Belonging to the company's shareholders	4	−8	8	–	−9	−38	–	–	−30	10	−7	−6	11	37	33	22	19	13	19	10
Belonging to outside owners of subsidiaries	0	–	–	–	0	–	–	–	1	0	–	0	0	1	–	0	−1	−1	–	0
Other comprehensive income	0	0	0	0	1	−3	0	0	1	−2	1	0	−2	2	−2	−3	−2	−1	−2	0
Total comprehensive income	4	−8	8	−2	−8	−40	−5	2	−28	8	−6	−6	9	40	31	19	16	11	17	10
Net margin	4.1%	−9.0%	8.0%	−2.8%	−8.6%	−68.6%	−4.7%	2.7%	−51.1%	10.1%	−7.3%	−7.6%	11.7%	24.2%	23.8%	15.9%	13.8%	8.8%	15.3%	7.8%
Earnings per share	₹1.56	−₹2.79	₹2.66	−₹0.80	−₹2.79	−₹12.97	−₹1.30	₹0.64	−₹9.63	₹3.41	−₹2.41	−₹2.01	₹3.94	₹12.71	₹11.79	₹7.49	₹6.48	₹4.36	₹6.66	₹3.40
Diluted earnings per share	₹1.56	−₹2.79	₹2.66	−₹0.80	−₹2.79	−₹12.97	−₹1.30	₹0.64	−₹9.63	₹3.41	−₹2.41	−₹2.01	₹3.94	₹12.71	₹11.79	₹7.47	₹6.43	₹4.34	₹6.61	₹3.34

Earnings per share in rupees, restated for later splits and bonuses.

Segment results by quarter

Consolidated, ₹ crore, quarters to Jun 2026.Fermenta Biotech segment results by year

Bulk drugs/chemicals
Revenue, ₹ crore
52
57
93
76
89
113
123
134
124
133
124
117
Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Profit, ₹ crore
−18
−19
3
−2
13
12
24
28
23
22
21
19
Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Property
Revenue, ₹ crore
2
41
4
2
3
38
11
4
2
2
2
2
Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Profit, ₹ crore
0
40
2
1
1
37
9
2
0
0
0
0
Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26

₹ crore	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue of all businesses	54	99	97	78	91	151	134	137	126	135	126	119
Company revenue, as in its results	57	99	97	78	95	156	140	136	130	137	122	122
Revenue	52	57	93	76	89	113	123	134	124	133	124	117
Revenue growth	−31.9%	26.4%	32.0%	34.7%	70.2%	97.0%	32.5%	76.9%	40.0%	17.7%	0.5%	−12.3%
Profit	−18	−19	3	−2	13	12	24	28	23	22	21	19
Profit growth	–	–	–	–	–	–	741.8%	–	76.8%	85.7%	−16.0%	−30.8%
Margin	−34.7%	−32.8%	3.1%	−2.9%	14.8%	10.5%	19.8%	20.6%	18.7%	16.6%	16.6%	16.2%
Assets	459	440	442	440	475	498	497	487	504	483	523	530
Liabilities	75	76	85	86	103	114	102	97	109	90	99	103
Capital employed	384	365	357	354	372	384	396	390	396	393	424	427
Revenue	2	41	4	2	3	38	11	4	2	2	2	2
Revenue growth	−90.0%	333.0%	−85.1%	−90.5%	21.6%	−7.3%	163.9%	43.8%	−24.5%	−94.6%	−82.7%	−43.9%
Profit	0	40	2	1	1	37	9	2	0	0	0	0
Profit growth	–	429.6%	−92.8%	−95.4%	–	−7.4%	381.5%	43.5%	−81.5%	−99.7%	−97.6%	−95.6%
Margin	−12.3%	95.6%	47.1%	44.3%	45.0%	95.5%	86.0%	44.2%	11.0%	4.7%	11.8%	3.4%
Assets	20	22	15	12	16	10	13	18	22	20	9	9
Liabilities	46	35	42	42	39	36	39	42	42	44	29	39
Capital employed	−26	−13	−27	−29	−23	−27	−26	−24	−20	−24	−21	−30
Revenue	5	3	5	3	7	8	9	8	10	6	1	7
Profit	0	0	−1	−1	1	1	1	2	3	1	−1	−2
Assets	116	100	91	73	49	89	104	123	125	136	116	128
Liabilities	191	161	135	118	111	119	115	110	115	116	119	112

Profit is before tax and finance costs, the way companies report their segments.